V025-0471 Screening compound: 2-[8-chloro-3-(3-methylphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1,2,3,4-tetrahydroisoquinoline

V025-0471 Screening compound: 2-[8-chloro-3-(3-methylphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1,2,3,4-tetrahydroisoquinoline
V025-0471 Screening compound: 2-[8-chloro-3-(3-methylphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1,2,3,4-tetrahydroisoquinoline alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-0471
2-[8-chloro-3-(3-methylphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1,2,3,4-tetrahydroisoquinoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-0471

Molecular Formula

C25H20ClN5 (C25 H20 ClN5)

Compound Name

2-[8-chloro-3-(3-methylphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1,2,3,4-tetrahydroisoquinoline

IUPAC name

2-[8-chloro-3-(3-methylphenyl)-[124]triazolo[43-c]quinazolin-5-yl]-1234-tetrahydroisoquinoline

SMILES

Cc1cccc(-c2nnc3n2c(N(CC2)Cc4c2cccc4)nc2c3ccc(Cl)c2)c1

InChI

InChI=1S/C25H20ClN5/c1-16-5-4-8-18(13-16)23-28-29-24-21-10-9-20(26)14-22(21)27-25(31(23)24)30-12-11-17-6-2-3-7-19(17)15-30/h2-10,13-14H,11-12,15H2,1H3

InChI Key

RZVKPARVNFZQSV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19922737

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

425.92

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.555

Distribution Coefficient, logD

6.368

Water Solubility, LogSw

-6.52

Polar Surface Area

32.655

Acid Dissociation Constant (pKa)

17.28

Base Dissociation Constant (pKb)

7.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.00

V025-0471 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V025-0471 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-0471?
Check Price and Availability of V025-0471, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-0471 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-0471
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-0471
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-0471 available by request